Items Tagged ‘Bavencio’

March 31st, 2017

FDA Approves Bavencio as First Treatment for Merkel Cell Cancer


The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC. According to the National Cancer Institute, approximately […]

View full entry

Tags: Bavencio, General, Merkel Cell Cancer, News, PD-1, Skin Cancer